Charlotte Hvelplund

Nordic Brand Manager Oncology at Astellas Nordic
  • Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Location
Copenhagen Metropolitan Area, DK

Topline Score

Topline score feature will be out soon.

Bio

Generated by
Topline AI

5.0

/5.0
/ Based on 2 ratings
  • (2)
  • (0)
  • (0)
  • (0)
  • (0)

Filter reviews by:

Gerard Bienfait

I’ve met Charlotte as a customer of MEDonline and was pleasantly surprised. Charlotte knows het markets, is strategically strong and at the same time Charlotte is very much hands on. Charlotte is no nonsense and straight to the point and also a nice person to work with.

Corin ten Hoeven

I have had the pleasure to collaborate with Charlotte during several steps in our careers. Charlotte has played an important role in making Jevtana a key product in the Nordic region and more recently she has been a driving factor for a successful launch of Libtayo in Denmark. Charlotte has often been invited for European and global sounding board groups. Her strategic insights and critical thinking has contributed to many improved projects/campaigns. Charlotte is a great teamplayer with an honest, open and transparent way of working.

You need to have a working account to view this content.
You need to have a working account to view this content.

Experience

    • Pharmaceutical Manufacturing
    • 1 - 100 Employee
    • Nordic Brand Manager Oncology
      • Aug 2021 - Present

  • Medical Access
    • Teknikerbyen, Nærum
    • Digital Medical Education Manager
      • Mar 2021 - Aug 2021

      We are providing access to knowledge, learning and training among doctors and healtcare professionals to improve health and patient care. We are providing access to knowledge, learning and training among doctors and healtcare professionals to improve health and patient care.

    • France
    • Pharmaceutical Manufacturing
    • 700 & Above Employee
    • Nordic & Baltic Brand Manager Oncology
      • Jan 2016 - Feb 2021

      Strategic head of a key oncology asset Libtayo, a PD1 antibody, for advanced cutaneous Squamous Cell Carcinoma, Basal Cell Carcinoma and Lung Cancer. Responsible for Nordic and Baltic market.Key Performance Indicators→ Preparing Nordic launch with local brand teams.→ Development of cross-country and cross-functional activities.→ Development of digital transformation strategy including content development including e- learning, webpages, newsletter, movie and mp4 files for digital campaign.→ Prelaunch activities of Libtayo in Nordic countries.→ Northern Light Award 2019 for Commit to Customers.Member of Nordic and Baltic Oncology Leadership Team.Member of the Libtayo EU Brand Team. Show less

    • Nordic & Baltic Brand Manager Oncology
      • May 2014 - Feb 2021

      Strategic head of key oncology asset for prostate cancer in the region.KPIs→ Consistently exceeding sales budget in 2014-2019.→ Best sales/capita in the world (DK), Sweden and Finland in TOP 5.→ Successful launch in Lithuania and relaunch in Norway.→ Double digits growth in all markets.→ Northern Light Award 2017 for Excellent Sales Achievement. → Global Business Innovation Award for National Treatment Guidelines in Prostate Cancer 2016. → Northern Light Award 2015 for teamwork.Responsible for Jevtana LOE planning in Nordic and Baltic markets.Member of Nordic and Baltic Oncology Leadership Team.Member of the Jevtana EU Brand Team. Successful implementation of shared marketing function at Nordic and Baltic level. Show less

    • Nordic & Baltic Brand Manager Oncology
      • 2014 - 2016

    • Product Manager Oncology
      • Apr 2011 - Apr 2014

      Successful launch of Jevtana for prostate cancer in a competitive market. Head of the Oncology brand team in Denmark.KPIs→ Best sales/capita in the world (value as well as volume).Project Management Award in 2012 for the Jevtana Stakeholder Empowerment Project with Prostate Cancer Patient Association.

    • United Kingdom
    • Pharmaceutical Manufacturing
    • 700 & Above Employee
    • Senior Product Manager Oncology
      • May 1999 - Apr 2011

      Successfully and flawless launch of Tyverb, a tyrosine kinase inhibitor for HER2+ metastatic breast cancer as head of launch team, 2008.KPIs→ 2nd best sales/capita in Europe.→ 4 out of 5 regions started using Tyverb at launch.→ No findings in marketing or sales in an audit for Tyverb launch. Late stage management of Lamictal for epilepsy, a 120 million DKK asset at patent expiry, 2005.Successful launches of new indications in lung cancer and cervix cancer (Hycamtin), 2006.Contributing to company strategy in Danish Task Force, a group under the Danish Leadership Team, 2009.Appointment as marketing lead for Nordic region in Tyverb International Product Strategy Team, 2010. Show less

    • Product Manager Oncology and CNS
      • 2003 - 2004

      Relaunch of ReQuip for Parkinson’s Disease, 2003.

    • New Business Development Associate
      • 2002 - 2003

      Heading up closure of co-promotion agreement with Roche on Bonviva for osteoporosis

    • Product Manager Diabetes
      • 1999 - 2002

    • External lecturer in Marketing
      • 1996 - 2002

    • United States
    • Pharmaceutical Manufacturing
    • 700 & Above Employee
    • Product Manager Diabetes
      • 1995 - 1999

      Launch of Eli Lilly´s insulin portfolio in Denmark, 1995.

    • Clinical Research Associate
      • 1995 - 1995

    • Key Account Specialist / Oncology Associate
      • 1994 - 1995

    • Product Specialist CNS
      • 1994 - 1994

    • Sales Representative CNS & Gastroenterology
      • 1991 - 1994

Education

  • Bigum&Co
    Digital Marketing, Marketing
    2020 - 2021
  • Cecilie Gredal
    Den karismagiske leder, Personal leadership
    2020 - 2021
  • Copenhagen Business School
    HD, 1 del Erhvervsret og Statistik
    1994 - 1996
  • Københavns Universitet - University of Copenhagen
    MSc (Pharm.)
    1984 - 1990
  • Risskov Amtsgymnasium
    Mat-Fys Studentereksamen
    1980 - 1983
  • Jellebakken

Community

You need to have a working account to view this content. Click here to join now